Open AccessSertraline for Prevention of Depression Recurrence in Diabetes Mellitus
Author(s) -
Patrick J. Lustman,
Ray E. Clouse,
Billy D. Nix,
Kenneth E. Freedland,
Eugene H. Rubin,
Janet B. McGill,
Monique Williams,
Alan J. Gelenberg,
Paul Ciechanowski,
Irl B. Hirsch
Publication year - 2006
Publication title -
archives of general psychiatry
Language(s) - English
Resource type - Journals
eISSN - 1538-3636
pISSN - 0003-990X
DOI - 10.1001/archpsyc.63.5.521
Subject(s) - sertraline , depression (economics) , placebo , medicine , diabetes mellitus , hazard ratio , randomization , glycemic , randomized controlled trial , surgery , confidence interval , endocrinology , antidepressant , alternative medicine , pathology , hippocampus , economics , macroeconomics
In patients with diabetes mellitus, depression is a prevalent and recurrent problem that adversely affects the medical prognosis.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom